FASCILIREN Trademark

Trademark Overview

On Tuesday, January 10, 2012, a trademark application was filed for FASCILIREN with the United States Patent and Trademark Office. The USPTO has given the FASCILIREN trademark a serial number of 85512898. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 31, 2015. This trademark is owned by Pfizer Inc.. The FASCILIREN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
fasciliren

General Information

Serial Number85512898
Word MarkFASCILIREN
Filing DateTuesday, January 10, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 31, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 5, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 13, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, August 31, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 31, 2015ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 28, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 27, 2015EXTENSION 5 GRANTED
Thursday, January 8, 2015EXTENSION 5 FILED
Thursday, January 8, 2015TEAS EXTENSION RECEIVED
Tuesday, August 5, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 4, 2014EXTENSION 4 GRANTED
Thursday, July 24, 2014EXTENSION 4 FILED
Thursday, July 24, 2014TEAS EXTENSION RECEIVED
Wednesday, January 22, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 21, 2014EXTENSION 3 GRANTED
Wednesday, January 8, 2014EXTENSION 3 FILED
Wednesday, January 8, 2014TEAS EXTENSION RECEIVED
Tuesday, August 6, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 5, 2013EXTENSION 2 GRANTED
Wednesday, July 3, 2013EXTENSION 2 FILED
Friday, August 2, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 3, 2013TEAS EXTENSION RECEIVED
Saturday, February 2, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 1, 2013EXTENSION 1 GRANTED
Thursday, January 17, 2013EXTENSION 1 FILED
Friday, February 1, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 17, 2013TEAS EXTENSION RECEIVED
Monday, January 14, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 31, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 5, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 5, 2012PUBLISHED FOR OPPOSITION
Wednesday, May 16, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 1, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 24, 2012ASSIGNED TO LIE
Thursday, April 5, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 27, 2012ASSIGNED TO EXAMINER
Friday, January 13, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 13, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

fasciliren preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases